Classification of Epilepsy generally defined by the International League against Epilepsy 2010 (ILAE):
1. focal seizures (no LOC)
2. focal dyscognitive seizures
3. partial seizures evolving to generalised tonic-clonic (GTC) convulsions
Other anti-epileptic agents following benzodiazepines:
Pharmacological agents |
|
|---|---|
| Benzopdiazepines (BZD's) | |
| • GABA-A rec modulators • so-called “BZ1” rec responsible for sedative, amnesic and some anti-convulsive effects • BZ2 recs mediate anxiolytic and muscle relaxant effects • hepatic metabolism with renal excretion • peripheral vasodilator action |
|
| Lorazepam | • high potency, short acting • anticonvulsant and useful adjunct in psychosis • unique degradation pathway allowing use in renal dysfunction |
| Midazolam | • high potency, short acting |
| Diazepam | • medium potency, long acting • active metabolites which prolong clinical effect |
| Clonazepam | • high potency, long acting • additional serotonin agonist property |
| Other Anti-Epileptic drugs | |
| Phenytoin | • 'membrane stabiliser' via Na+ blockade • contraindicated with heart blocks • t1/2 = 22/24 |
| Phenobarbital | • binds to GABAA but with lower specificity than benzo's • t1/2 = 50-140/24 |
| Propofol | • binds to GABAA causing global CNS depression • t1/2 = 40mins the 24+/24 after infusion |
Presentation and Mx in acute setting - RCP - 2018
https://emedicine.medscape.com/article/1609294-overview
https://www.nice.org.uk/guidance/cg137
Dx and Mx of epilepsy in Adults - SIGN 2018
https://www.aci.health.nsw.gov.au/networks/eci/clinical/clinical-resources/clinical-tools/neurology/seizures
https://emergencymedicinecases.com/status-epilepticus/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684331/\ Benzodiazepine pharmacology and CNS
Intensive Care review Phenytoin
https://derangedphysiology.com/main/required-reading/neurology-and-neurosurgery/Chapter%20311/management-status-epilepticus-icu
Lancet 2020. Efficacy of levetiracetam, phenytoin, valproate in status